![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/BIOFILCHEM.png)
Share the post "Biofil Chemicals & Pharmaceuti Shareholding pattern FY(Q3-Dec 2024-2025)"
Shareholding results summarize the composition of a company’s shareholder base, revealing how ownership is distributed among various investors. This information is crucial for assessing the level of institutional and retail investment in the company. By examining shareholding results, analysts can gauge investor sentiment and the potential impact on stock performance. Biofil Chemicals & Pharmaceuti has released its latest shareholding reports, covering the third quarter and the fiscal year ending on (Q3-Dec 2024-2025).This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.
| Shareholder Name | Previous Quarter Quantity | Current Quarter Quantity | Previous Quarter Shares(in %) | Current Quarter Shares(in %) | Quarter to Quarter Difference |
|---|---|---|---|---|---|
| Promoters | 76.19 Lakh | 76.19 Lakh | 46.82 | 46.82 | 0 |
| Public | 86.55 Lakh | 86.55 Lakh | 53.1 | 53.1 | 0 |
| DII | 13.20 K | 13.20 K | 0.08 | 0.08 | 0 |
| FII | 185 | 135 | 0 | 0 | 0 |
| Government | 0 | 0 | 0 | 0 | 0 |
Promoters shareholding remained stable, at 46.82% in both September 2024- and December 2024-. This indicates that the promoters’ control over the company did not change during this period. Public shareholding remained consistent, holding steady at 53.1% in both September 2024- and December 2024-. This indicates that the Public control over the company did not change during this period. DIIs (Domestic Institutional Investors) shareholding remained unchanged at 0.08% from September 2024- to December 2024-. This indicates that domestic institutions maintained their investment level in the company. FIIs (Foreign Institutional Investors) shareholding remained at 0% from September 2024- to December 2024-. , indicating no change in the investment levels by foreign institutions in the company.
Below is a detailed table showcasing the public shareholding percentage.
| Shareholder Name | Previous Quarter Quantity | Current Quarter Quantity | Previous Quarter Shares (in %) | Current Quarter Shares (in %) | Quarter-to-Quarter Difference (%) |
|---|---|---|---|---|---|
| Resident Individuals holding nominal share capital up to Rs. 2 lakhs | 54.77 Lakh | 56.06 Lakh | 33.66 | 34.45 | + 0.79 % |
| Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs | 7.10 Lakh | 6.08 Lakh | 4.36 | 3.74 | -0.62 % |
| Non Resident Indians (NRIs) | 2.02 Lakh | 1.93 Lakh | 1.24 | 1.18 | -0.06 % |
| Bodies Corporate | 20.70 Lakh | 20.39 Lakh | 12.72 | 12.53 | -0.19 % |
| Any Other (specify) | 1.82 Lakh | 1.97 Lakh | 1.12 | 1.21 | + 0.09 % |
| HUF | 1.10 Lakh | 1.26 Lakh | 0.68 | 0.78 | + 0.1 % |
| JAYESH J HAPANI | 2.00 Lakh | 0 | 1.23 | 0 | -1.23% |
Leading the way to higher stakeholding, Resident Individuals holding nominal share capital up to Rs. 2 lakhs has significantly boosted stakeholding by an impressive 0.79 %.Observations show a significant difference of -0.62 % in Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs’s financial performance between quarters.Observations show a significant difference of -0.06 % in Non Resident Indians (NRIs)’s financial performance between quarters.Observations show a significant difference of -0.19 % in Bodies Corporate’s financial performance between quarters.Leading the way to higher stakeholding, Any Other (specify) has significantly boosted stakeholding by an impressive 0.09 %.Leading the way to higher stakeholding, HUF has significantly boosted stakeholding by an impressive 0.1 %.JAYESH J HAPANI had 1.23% of shares in the previous quarter but exited in the current quarter.
[my_shortcode1 values=”Biofil Chemicals & Pharmaceuti”]
